Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""HEPATITIS B"" wg kryterium: Temat


Tytuł :
Real-world prevalence of hepatitis B virus reactivation in cancer patients in Taiwan.
Autorzy :
Chen CH; Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.
Hsieh HH; Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.
Wu TY; Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.; Department of Pharmacology, School of Medicine, Tzu Chi University, Hualien, Taiwan.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Jan; Vol. 27 (1), pp. 63-70. Date of Electronic Publication: 2020 Apr 07.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B virus*
Hepatitis B/*complications
Hepatitis B/*epidemiology
Neoplasms/*complications
Neoplasms/*epidemiology
Virus Activation/*drug effects
Adult ; Aged ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Antiviral Agents/therapeutic use ; Female ; Hepatitis B/virology ; Hepatitis B Surface Antigens/analysis ; Humans ; Incidence ; Male ; Mass Screening ; Middle Aged ; Prevalence ; Retrospective Studies ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Transplanting Kidneys From Donors With Chronic Hepatitis B: Bringing Transmission Risk Closer to Zero.
Autorzy :
Terrault NA; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Mar 15; Vol. 72 (6), pp. 1024-1025.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Hepatitis B, Chronic*/epidemiology
Hepatitis B, Chronic*/prevention & control
Kidney Transplantation*
China ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Humans ; Kidney ; Living Donors ; Tissue Donors
Czasopismo naukowe
Tytuł :
Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
Autorzy :
Nayagam S; Section of Hepatology and Gastroenterology, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United Kingdom.; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London,UK.
Chan P; World Health Organization China office, Beijing, China.
Zhao K; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Sicuri E; Health Economics Group, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Wang X; National Center for AIDS Control and Prevention (NCAIDS), China Center for Disease Control and Prevention, Beijing, China.
Jia J; Liver Research Center, Beijing Friendship Hospital, Beijing, China.
Wei L; Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.
Walsh N; World Health Organization regional office for the Western Pacific, Manila, Philippines.
Rodewald LE; World Health Organization China office, Beijing, China.
Zhang G; National Immunization Programme, China Center for Disease Control and Prevention, Beijing, China.
Ailing W; National Center for Women and Children's Health, China Center for Disease Control and Prevention, Beijing, China.
Zhang L; World Health Organization China office, Beijing, China.
Chang JH; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Hou W; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Qiu Y; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Sui B; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Xiao Y; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Zhuang H; Department of Microbiology and Infectious Disease Center, Peking University Health Science Center, Beijing, China.
Thursz MR; Section of Hepatology and Gastroenterology, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United Kingdom.
Scano F; World Health Organization China office, Beijing, China.
Low-Beer D; World Health Organization, Geneva, Switzerland.
Schwartländer B; World Health Organization, Geneva, Switzerland.
Wang Y; China Center for Disease Control and Prevention, Beijing, China.
Hallett TB; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London,UK.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Mar 01; Vol. 72 (5), pp. 743-752.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B*/drug therapy
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Hepatitis B, Chronic*/prevention & control
Antiviral Agents/therapeutic use ; China/epidemiology ; Hepatitis B Vaccines/therapeutic use ; Hepatitis B virus ; Humans
Czasopismo naukowe
Tytuł :
Screening for Hepatitis B in Nonpregnant Adolescents and Adults.
Autorzy :
Jin J; Associate Editor, JAMA.
Pokaż więcej
Źródło :
JAMA [JAMA] 2020 Dec 15; Vol. 324 (23), pp. 2452.
Typ publikacji :
Patient Education Handout
MeSH Terms :
Hepatitis B virus*/immunology
Hepatitis B Surface Antigens/*blood
Hepatitis B, Chronic/*diagnosis
Mass Screening/*standards
Adolescent ; Adult ; Hepatitis B Vaccines ; Humans ; Mass Screening/adverse effects ; Risk Factors
Tytuł :
Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
Autorzy :
Krist AH; Fairfax Family Practice Residency, Fairfax, Virginia.; Virginia Commonwealth University, Richmond.
Davidson KW; Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York.
Mangione CM; University of California, Los Angeles.
Barry MJ; Harvard Medical School, Boston, Massachusetts.
Cabana M; University of California, San Francisco.
Caughey AB; Oregon Health & Science University, Portland.
Donahue K; University of North Carolina at Chapel Hill.
Doubeni CA; Mayo Clinic, Rochester, Minnesota.
Epling JW Jr; Virginia Tech Carilion School of Medicine, Roanoke.
Kubik M; George Mason University, Fairfax, Virginia.
Ogedegbe G; New York University, New York, New York.
Owens DK; Stanford University, Stanford, California.
Pbert L; University of Massachusetts Medical School, Worcester.
Silverstein M; Boston University, Boston, Massachusetts.
Simon MA; Northwestern University, Evanston, Illinois.
Tseng CW; University of Hawaii, Honolulu.; Pacific Health Research and Education Institute, Honolulu, Hawaii.
Wong JB; Tufts University School of Medicine, Boston, Massachusetts.
Pokaż więcej
Corporate Authors :
US Preventive Services Task Force
Źródło :
JAMA [JAMA] 2020 Dec 15; Vol. 324 (23), pp. 2415-2422.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B virus*/immunology
Hepatitis B Surface Antigens/*blood
Hepatitis B, Chronic/*diagnosis
Mass Screening/*standards
Adolescent ; Adult ; Emigrants and Immigrants ; Hepatitis B Vaccines ; Humans ; Mass Screening/adverse effects ; Risk Factors ; United States
Czasopismo naukowe
Tytuł :
Serum hepatitis B virus ribonucleic acid and its influencing factors in chronic hepatitis B.
Autorzy :
Zhou Y; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Peng Y; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Yuan H; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Long Z; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Wu S; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Yang J; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Pokaż więcej
Źródło :
Advances in clinical and experimental medicine : official organ Wroclaw Medical University [Adv Clin Exp Med] 2021 Apr; Vol. 30 (4), pp. 361-367.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B virus*/genetics
Hepatitis B, Chronic*/diagnosis
DNA, Viral/genetics ; Hepatitis B e Antigens ; Humans ; RNA
Czasopismo naukowe
Tytuł :
[New insights into immunotolerant phase of chronic hepatitis B virus infection].
Autorzy :
Duan MH; Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Liu XE; Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Zhuang H; Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Mar 20; Vol. 29 (3), pp. 284-288.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B, Chronic*
Liver Neoplasms*
DNA, Viral ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Immune Tolerance
Czasopismo naukowe
Tytuł :
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis.
Autorzy :
Brunetto MR; Pisa, Italy.
Carey I; London, UK.
Maasoumy B; Hannover, Germany.
Marcos-Fosch C; Barcelona, Spain.
Boonstra A; Rotterdam, the Netherlands.
Caviglia GP; Turin, Italy.
Loglio A; Milan, Italy.
Cavallone D; Pisa, Italy.
Scholtes C; Lyon, France.
Ricco G; Pisa, Italy.
Smedile A; Turin, Italy.
Riveiro-Barciela M; Barcelona, Spain.
van Bömmel F; Leipzig, Germany.
van der Eijk A; Rotterdam, the Netherlands.
Zoulim F; Lyon, France.
Berg T; Leipzig, Germany.
Cornberg M; Hannover, Germany.
Lampertico P; Milan, Italy.
Agarwal K; London, UK.
Buti M; Barcelona, Spain.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (6), pp. 733-744. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B e Antigens*
Hepatitis B, Chronic*/diagnosis
Adult ; DNA, Viral/genetics ; Female ; Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Humans ; Male ; Prospective Studies ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Hepatitis B virus antigen peptide presentation by Epstein-Barr virus-transformed peripheral blood B cells].
Autorzy :
Yi X; Infectious Diseases Department, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.
Wen CH; Infectious Diseases Department, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.
Gu SQ; Infectious Diseases Department, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.
Guo L; Infectious Diseases Department, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.
Tang LB; Infectious Diseases Department, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.
Wang WB; Infectious Diseases Department, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Mar 20; Vol. 29 (3), pp. 240-245.
Typ publikacji :
Journal Article
MeSH Terms :
Epstein-Barr Virus Infections*
Hepatitis B*
Hepatitis B, Chronic*
B-Lymphocytes ; Hepatitis B virus ; Herpesvirus 4, Human ; Humans ; Leukocytes, Mononuclear
Czasopismo naukowe
Tytuł :
[Analysis of clinical characteristics of 481 HBV-related liver cirrhotic patients with low viral load].
Autorzy :
Huang X; Department of Infectious Disease, Infectious Disease Center of the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830000, China.
Yao L; Department of Infectious Disease, Infectious Disease Center of the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830000, China.
Deng ZR; Department of Infectious Disease, Infectious Disease Center of the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830000, China.
Dong J; Department of Infectious Disease, Infectious Disease Center of the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830000, China.
Zheng RJ; Department of Infectious Disease, Infectious Disease Center of the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830000, China.
Lu XB; Department of Infectious Disease, Infectious Disease Center of the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830000, China.
Zhang YX; Department of Infectious Disease, Infectious Disease Center of the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830000, China.
Sun LH; Department of Infectious Disease, Infectious Disease Center of the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830000, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Mar 20; Vol. 29 (3), pp. 227-233.
Typ publikacji :
Journal Article
MeSH Terms :
DNA, Viral*
Hepatitis B virus*/genetics
Adult ; Aged ; Aged, 80 and over ; Female ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Humans ; Liver Cirrhosis ; Male ; Middle Aged ; Retrospective Studies ; Viral Load ; Young Adult
Czasopismo naukowe
Tytuł :
Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.
Autorzy :
Falade-Nwulia O; Johns Hopkins University, Baltimore, Maryland.
Seaberg EC; Johns Hopkins University, Baltimore, Maryland.
Snider AE; Johns Hopkins University, Baltimore, Maryland.
Rinaldo CR; Departments of Pathology and Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Wolinsky SM; Department of Medicine, Feinberg School of Medicine, Northwestern University Chicago, Chicago, Illinois.
Witt MD; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
Thio CL; Johns Hopkins University, Baltimore, Maryland.
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2021 May 01; Vol. 35 (6), pp. 991-993.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms :
HIV Infections*/complications
HIV Infections*/drug therapy
Hepatitis B*/complications
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Antiretroviral Therapy, Highly Active ; Cohort Studies ; Hepatitis B virus ; Humans ; Male
Czasopismo naukowe
Tytuł :
Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
Autorzy :
Preininger L; William J. Holloway Community Program, Christiana Care Health System, Wilmington, Delaware, USA.
Kahal DA
Szabo S
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2021 Apr 01; Vol. 35 (5), pp. 845-846.
Typ publikacji :
Journal Article
MeSH Terms :
HIV Infections*/drug therapy
Hepatitis B*/prevention & control
Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Hepatitis B Vaccines ; Humans ; Vaccination
Czasopismo naukowe
Tytuł :
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load.
Autorzy :
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Yang WT; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Hsu CY; Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Hong CM; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tsai CH; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen HH; Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Apr; Vol. 53 (8), pp. 908-918. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B, Chronic*/complications
DNA, Viral ; Disease Progression ; Hepatitis B Core Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Symptom Flare Up ; Viral Load
Czasopismo naukowe
Tytuł :
[Risk analysis for hepatocellular carcinoma in patients with chronic hepatitis B-associated cirrhosis complicated by type 2 diabetes mellitus: a 5-year prospective cohort study].
Autorzy :
Tang C; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Hu C; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhou Y; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510310, China.
Song Y; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Li M; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Liao M; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Sun J; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhong C; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhou L; Department of Endocrinology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Lin Z; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhou Y; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Pokaż więcej
Źródło :
Nan fang yi ke da xue xue bao = Journal of Southern Medical University [Nan Fang Yi Ke Da Xue Xue Bao] 2021 Mar 25; Vol. 41 (3), pp. 313-318.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/etiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Adult ; Antiviral Agents/therapeutic use ; Hepatitis B virus ; Humans ; Liver Cirrhosis/complications ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/epidemiology ; Prospective Studies ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł :
Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
Autorzy :
Wang XD; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Liu JP; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Song TR; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Huang ZL; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Fan Y; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Shi YY; Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Chen LY; Department of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lv YH; West China School of Clinical Medicine, Sichuan University, Chengdu, Sichuan, China.
Xu ZL; West China School of Clinical Medicine, Sichuan University, Chengdu, Sichuan, China.
Li XH; Department of Health Statistics, West China School of Public Health, Sichuan University, Chengdu, Sichuan, China.
Wang L; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lin T; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Mar 15; Vol. 72 (6), pp. 1016-1023.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B*/epidemiology
Kidney Transplantation*
China/epidemiology ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Hepatitis B virus ; Humans ; Living Donors ; Retrospective Studies ; Tissue Donors
Czasopismo naukowe
Tytuł :
Treatment eligibility in hepatitis B: a call for better linkage to optimal care.
Autorzy :
Huang DQ; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Gastroenterology and Hepatology, National University Health System, Singapore.
Nguyen MH; Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA; Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA 94304, USA. Electronic address: .
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2021 Mar; Vol. 6 (3), pp. 160.
Typ publikacji :
Letter; Comment
MeSH Terms :
Hepatitis B*/diagnosis
Hepatitis B*/drug therapy
Hepatitis B*/epidemiology
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Hepatitis B, Chronic*/prevention & control
Antiviral Agents/therapeutic use ; Hepatitis B Surface Antigens ; Humans
Opinia redakcyjna
Tytuł :
Extending treatment eligibility for chronic hepatitis B virus infection.
Autorzy :
McNaughton AL; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Lemoine M; Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Division of Digestive Diseases, Section of Hepatology and Gastroenterology, Imperial College, London, UK.
van Rensburg C; Division of Gastroenterology, Department of Medicine, Tygerberg Academic Hospital, Cape Town, South Africa.
Matthews PC; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK. .; Department of Microbiology and Infectious Diseases, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK. .
Pokaż więcej
Źródło :
Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2021 Mar; Vol. 18 (3), pp. 146-147.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Eligibility Determination*
Hepatitis B Vaccines*
Antiviral Agents/*therapeutic use
Hepatitis B, Chronic/*epidemiology
Hepatitis B, Chronic/*prevention & control
Hepatitis B, Chronic/transmission ; Humans
Czasopismo naukowe
Tytuł :
[Epidemiology and influencing factors of human immunodeficiency virus and hepatitis B virus co-infected patients in Beijing].
Autorzy :
Li Y; Department of Infectious Disease,Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100005, China.
Zhang L; Department of Infectious Disease,Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Xiao J; Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Jiang TY; Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Liu ZY; Department of Infectious Disease,Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Pokaż więcej
Źródło :
Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2021 Mar 01; Vol. 60 (3), pp. 233-238.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-HIV Agents*/therapeutic use
Coinfection*/epidemiology
HIV Infections*/complications
HIV Infections*/epidemiology
Hepatitis B*/complications
Hepatitis B*/epidemiology
Adult ; HIV ; Hepatitis B virus ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply.
Autorzy :
Pol S; Université de Paris, Paris, France.; INSERM U-1223, Institut Pasteur, Paris, France.; Assistance Publique - Hôpitaux de Paris, Hôpital Cochin, Unité d'Hépatologie, Paris, France.
Luzivika Nzinga C; Sorbonne Université, Institut National de la santé et de la Recherche Médicale, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
Fontaine H; Assistance Publique - Hôpitaux de Paris, Hôpital Cochin, Unité d'Hépatologie, Paris, France.
Carrat F; Sorbonne Université, Institut National de la santé et de la Recherche Médicale, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.; Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France.
Pokaż więcej
Corporate Authors :
French ANRS CO22 Hepather cohort
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (5), pp. 659.
Typ publikacji :
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Antiviral Agents/adverse effects ; Europe/epidemiology ; Guanine/analogs & derivatives ; Hepatitis B virus ; Humans ; Tenofovir/adverse effects
Raport
Tytuł :
Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort.
Autorzy :
Pol S; Assistance Publique - Hôpitaux de Paris, Hôpital Cochin, Unité d'Hépatologie, Paris, France.; Université Paris Descartes, INSERM U-1223, Institut Pasteur, Paris, France.
Pokaż więcej
Corporate Authors :
ANRS/AFEF study group
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (5), pp. 616-629. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Antiviral Agents/adverse effects ; Guanine/analogs & derivatives ; Hepatitis B virus ; Humans ; Prospective Studies ; Tenofovir/adverse effects ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies